AN2 Therapeutics, Inc.
ANTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001880438
In the last 90 days, AN2 Therapeutics, Inc. insiders filed 1 open-market purchase and 5 sales; 66 institutions reported holding it in 13F filings for Q2 2026, worth $119.0M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in AN2 Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +2 vs. Q4 2022
- Shares held
- 9.60M
- −162.4K (−1.7%) vs. Q4 2022
- Total value
- $94.8M
- +$1.82M (+2.0%) vs. Q4 2022
- New holders
- 3
- 20 more added
- Sold out
- 1
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 66 | $119.0M |
| Q1 2026 | 52 | $74.8M |
| Q4 2025 | 38 | $9.88M |
| Q3 2025 | 36 | $10.5M |
| Q2 2025 | 37 | $8.78M |
| Q1 2025 | 38 | $19.5M |
| Q4 2024 | 38 | $20.1M |
| Q3 2024 | 31 | $14.5M |
| Q2 2024 | 45 | $41.7M |
| Q1 2024 | 54 | $60.9M |
| Q4 2023 | 51 | $417.9M |
| Q3 2023 | 37 | $320.3M |
| Q2 2023 | 31 | $99.9M |
| Q1 2023 | 38 | $94.8M |
| Q4 2022 | 36 | $92.9M |
| Q3 2022 | 38 | $165.1M |
| Q2 2022 | 36 | $72.4M |
| Q1 2022 | 18 | $134.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding AN2 Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $1.97K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 307 | $3.03K | 0.00% | +56+22.3% | Added |
| Ameritas Investment Partners, Inc. | 348 | $3.44K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 642 | $6.00K | 0.00% | −1,109−63.3% | Reduced |
| Legal & General Group Plc | 1,166 | $11.6K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,767 | $17.0K | 0.00% | −85−4.6% | Reduced |
| Wells Fargo & Company | 1,966 | $19.4K | 0.00% | +1,966 | New |
| STRS Ohio | 2,300 | $22.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,797 | $28.0K | 0.00% | +1,941+226.8% | Added |
| California State Teachers Retirement System | 4,131 | $40.8K | 0.00% | −305−6.9% | Reduced |
| American International Group, Inc. | 5,362 | $52.9K | 0.00% | +107+2.0% | Added |
| New York State Common Retirement Fund | 5,879 | $58.0K | 0.00% | +54+0.9% | Added |
| ETF Managers Group, LLC | 6,742 | $66.5K | 0.00% | +6,742 | New |
| Deutsche Bank AG | 6,815 | $67.3K | 0.00% | +2,026+42.3% | Added |
| JPMorgan Chase & Co | 8,511 | $84.0K | 0.00% | +2,247+35.9% | Added |
| Rhumbline Advisers | 11,710 | $116.0K | 0.00% | +1,628+16.1% | Added |
| Nuveen Asset Management, LLC | 15,546 | $153.0K | 0.00% | +481+3.2% | Added |
| Private Advisor Group, LLC | 22,008 | $217.2K | 0.00% | +11,000+99.9% | Added |
| Bank of America Corp | 25,916 | $255.8K | 0.00% | +1,202+4.9% | Added |
| Charles Schwab Investment Management Inc | 29,898 | $295.1K | 0.00% | +5,000+20.1% | Added |
| Bank of New York Mellon Corp | 31,684 | $312.7K | 0.00% | +824+2.7% | Added |
| Barclays PLC | 32,773 | $323.5K | 0.00% | +2,715+9.0% | Added |
| Morgan Stanley | 45,532 | $449.4K | 0.00% | +4,227+10.2% | Added |
| Alyeska Investment Group, L.P. | 48,426 | $478.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 52,225 | $515.5K | 0.00% | +770+1.5% | Added |
| Bridgeway Capital Management, LLC | 52,500 | $518.2K | 0.01% | +52,500 | New |
| Northern Trust Corp | 76,134 | $751.4K | 0.00% | −4,684−5.8% | Reduced |
| State Street Corp | 96,884 | $956.2K | 0.00% | +5,862+6.4% | Added |
| Citigroup Inc | 134,473 | $1.33M | 0.00% | −75−0.1% | Reduced |
| Geode Capital Management, LLC | 144,947 | $1.43M | 0.00% | +21,862+17.8% | Added |
| Monashee Investment Management LLC | 247,467 | $2.44M | 0.67% | −202,533−45.0% | Reduced |
| BlackRock Inc. | 483,429 | $4.77M | 0.00% | +38,220+8.6% | Added |
| Vanguard Group Inc | 601,925 | $5.94M | 0.00% | +12,525+2.1% | Added |
| Avidity Partners Management LP | 723,200 | $7.14M | 0.24% | −20,400−2.7% | Reduced |
| Citadel Advisors LLC | 1,337,159 | $13.2M | 0.01% | +1760.0% | Added |
| BVF Inc | 1,563,963 | $15.4M | 0.56% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,773,517 | $37.2M | 0.84% | 00.0% | Unchanged |
| Woodline Partners LP | 0 | $0 | 0.00% | −107,300−100.0% | Sold out |